ctrl K

Price Alert

Viking Therapeutics Inc. (VKTX)

NASDAQ: VKTX · Real-Time Price · USD

40.04

-0.20 (-0.50%)

At close: Aug 15, 2025, 3:59 PM

40.02

-0.05%

After-hours: Aug 15, 2025, 04:11 PM EDT

Viking Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	26.68M	55.52M	36.63M	26.37M
Short-Term Investments	875.94M	306.56M	118.85M	175.73M
Long-Term Investments	n/a	n/a	n/a	n/a
Other Long-Term Assets	102K	139K	71K	109K
Receivables	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	1.13M	2.52M	3.41M	7.81M
Total Current Assets	907.22M	367.23M	167.04M	210.53M
Property-Plant & Equipment	1M	1.13M	1.42M	25K
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	1.1M	1.26M	1.49M	134K
Total Assets	908.32M	368.49M	168.53M	210.66M
Account Payables	9.81M	7.51M	8.53M	1.44M
Deferred Revenue	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	304K	29K
Other Current Liabilities	17.11M	n/a	-304K	-29K
Total Current Liabilities	27.41M	19.14M	21.95M	8.78M
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	630K	936K	1.26M	n/a
Total Liabilities	28.04M	20.07M	23.21M	8.78M
Total Debt	1.12M	1.26M	1.56M	29K
Common Stock	1K	1K	1K	1K
Retained Earnings	-487.91M	-377.94M	-292.05M	-223.18M
Comprehensive Income	-788K	-389K	-1.1M	-549K
Shareholders Equity	880.28M	348.42M	145.32M	201.88M
Total Investments	875.94M	306.56M	118.85M	175.73M